中國重工(601989.SH):公司股票將自8月13日起連續停牌,直至終止上市,不再復牌
格隆匯8月4日丨中國重工(601989.SH)公佈,公司於2025年8月5日發佈《中國船舶重工股份有限公司關於中國船舶工業股份有限公司換股吸收合併中國船舶重工股份有限公司暨關聯交易事項異議股東現金選擇權實施公吿》,將通過網下申報的方式向中國重工異議股東實施其所持異議股份的現金選擇權。為確保異議股東現金選擇權的實施順利進行,公司股票將自2025年8月13日(即異議股東現金選擇權申報日)開市起連續停牌,直至終止上市,不再復牌。2025年8月12日為公司A股股票最後一個交易日。敬請廣大投資者注意。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.